Dupont Capital Management’s Rigel Pharmaceuticals RIGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-6,118
| Closed | -$183K | – | 1734 |
|
|
2022
Q1 | $183K | Sell |
6,118
-541
| -8% | -$16.2K | 0.01% | 1080 |
|
|
2021
Q4 | $176K | Sell |
6,659
-10,064
| -60% | -$266K | 0.01% | 1161 |
|
|
2021
Q3 | $607K | Buy |
16,723
+3,251
| +24% | +$118K | 0.02% | 786 |
|
|
2021
Q2 | $585K | Hold |
13,472
| – | – | 0.01% | 892 |
|
|
2021
Q1 | $461K | Sell |
13,472
-2,763
| -17% | -$94.5K | 0.01% | 983 |
|
|
2020
Q4 | $568K | Sell |
16,235
-1,212
| -7% | -$42.4K | 0.01% | 796 |
|
|
2020
Q3 | $419K | Buy |
17,447
+5,222
| +43% | +$125K | 0.01% | 835 |
|
|
2020
Q2 | $224K | Buy |
+12,225
| New | +$224K | ﹤0.01% | 1087 |
|